Company Overview

Development Stage

About the Company

复星医药(股票代码:600196.SH,02196.HK)成立于1994年,是一家植根中国、创新驱动的全球化医药健康产业集团,业务涵盖制药、医疗器械、医学诊断、医疗健康服务等众多领域。集团以“4IN”战略(创新、国际化、智能化、整合)为指引,秉持“持续创新、乐享健康”的理念,致力于成为全球先进的医疗创新整合者。根据国家工信部中国医药工业信息中心颁布的“2024年度中国医药工业百强企业榜单”,复星医药位列第5位,同时连续第三年入选“全球医药企业研发管线规模Top25”,位列全球第十七位,并获得2025年《财富》中国ESG影响力榜单,入选2025福布斯中国人工智能科技企业TOP 50榜单。

复星医药国内营销平台是复星医药面向患者和终端,全力打造的全渠道、生态化的商业化平台。业务主要涵盖实体肿瘤、血液肿瘤、罕见病肿瘤、慢性肾病、自身免疫性疾病、消化、心血管等领域。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

复星医药国内营销平台 How Fast Is Hiring Growing? (142 open positions)

Manage
Note: How fast is hiring at 复星曜泓(江苏)医药科技有限公司 growing? 复星医药国内营销平台2026: 534 openings (down 28%), 2025: 742 openings (up 95%), 2024: 380 openings (up 265%), 2023: 104 openings (down 5%), 2022: 109 openings (down 75%), 2021: 432 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

复星医药国内营销平台 Master's Degree Job Demand Analysis

(More)
复星医药国内营销平台 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 复星曜泓(江苏)医药科技有限公司 growing? 复星医药国内营销平台Master's recruitment over the years: 2025: 20 openings (up 95%), 2023: 2 openings (down 5%), 2022: 13 openings (down 75%), 2021: 10 openings.

复星医药国内营销平台 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
复星医药国内营销平台 Doctoral Hiring by Year: 2023 — same as 2022
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 复星曜泓(江苏)医药科技有限公司 growing? 复星医药国内营销平台Doctorate recruitment over the years: 2023: 1 openings (down 5%), 2022: 1 openings (down 75%).

复星医药国内营销平台 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 复星曜泓(江苏)医药科技有限公司? Based on an analysis of 复星医药国内营销平台's job postings over the past year, "医疗卫生/美容保健类" demand: 41.2%, "计算机/网络/技术类": 35.1%, "生物/制药/化工/环保类": 1.5%, "美术/设计/创意类": 0.3%, "科研类": 0.1%. For reference only.

复星医药国内营销平台 — What Are the Salaries Like? (687 records)

Manage
复星医药国内营销平台 Salary Overview
salary range: 3K - 50K, 53% of roles pay ¥8-15K
Note: salary statistics are based on 687 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 复星曜泓(江苏)医药科技有限公司?复星医药国内营销平台53% of positions earn 8-15K, Fresh graduate salary: ¥4.2K。Xuzhou salary ranking top 15,销售类 average salary ¥14.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 复星医药国内营销平台

(More)
Are salaries high at 复星曜泓(江苏)医药科技有限公司? We provide: 信息,医药代表,地区经理,实习生,销售,零售,msl,医学联络官,hr,ka,临床,市场,bp,产品经理,项目经理,ra,推广,pm,培训,ma. Click to view detailed salary analysis by job.

复星医药国内营销平台 Related Industry Tags

Job Category

  • 销售类
    76.1% of total 76.1%
  • 医疗卫生/美容保健类
    40.6% of total 40.6%
  • 计算机/网络/技术类
    35% of total 35%
  • 经营管理类
    11.8% of total 11.8%

Education

  • 大专
    55.1% of total 55.1%
  • 本科
    34.4% of total 34.4%
  • 硕士
    5.8% of total 5.8%
  • 不限
    4.6% of total 4.6%

Experience

  • 1-3年
    52.7% of total 52.7%
  • 不限
    20% of total 20%
  • 5-10年
    14.8% of total 14.8%
  • 3-5年
    10.2% of total 10.2%
View Detailed Analysis

What does 复星曜泓(江苏)医药科技有限公司 require? Who is 复星医药国内营销平台 hiring? 复星医药国内营销平台 recruitment: 销售类占比最多占76.1%,其次是医疗卫生/美容保健类占40.6%. What education can get in at 复星医药国内营销平台? 大专占比最多占55.1%,其次是本科占34.4%. High education required at 复星医药国内营销平台? 硕士占5.8%,博士占0.1%. Work experience required at 复星医药国内营销平台? 1-3年占比最多占52.7%,其次是不限占20%. Where are the job locations at 复星医药国内营销平台? 上海占比最多占15%,其次是北京占6.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 28,001万(元)
Legal Representative: 邓长江
Date Established:
Credit Code: 91320300330835537W
Registered Address: 徐州经济技术开发区杨山路北侧

People who follow 复星医药国内营销平台 also follow

复星医药国内营销平台 Competitors (Similar Companies)

药物研发 生物制品 新药研发 生物化学
“Leading enterprise in the field of central nervous system drugs in Chi”
“Promoting human health”
“Research, development, and production of anti-tumor and surgical medic”
“Mission: To make it easier to develop drugs and cure diseases, to prov”
彩超 医疗护理 大健康 关节镜
药物研发 CRO 临床用药 科学服务
“Creating a sustainable and brighter future together”
医药 医药服务 CRO 临床研究
“Technological innovation and commercial application of pharmaceutical ”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“Experts in global pharmaceutical and healthcare”
“Biological diagnostic reagents and pharmaceuticals”
减速机 工程施工 环保科技 环保/节能
临床研究 药物研发 新药研发 转化医学

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates